» Articles » PMID: 35714169

Comprehensive Analysis of Congenital Adrenal Hyperplasia Using Long-Read Sequencing

Overview
Journal Clin Chem
Specialty Biochemistry
Date 2022 Jun 17
PMID 35714169
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that has been included in newborn screening programs. Current approaches to gene testing for CAH are facing challenges because of the complexity of the CYP21A2 locus and genetic heterogeneity of the disease.

Methods: A comprehensive analysis of CAH (CACAH) combining long-range locus-specific PCR and long-read sequencing (LRS) was developed to perform full sequence analysis of 5 common CAH candidate genes, including CYP21A2, CYP11B1, CYP17A1, HSD3B2, and StAR. In a blind retrospective study, the clinical utility of CACAH was evaluated in 37 samples by comparing to standard CAH testing using multiplex ligation-dependent probe amplification (MLPA) plus Sanger sequencing.

Results: Of the 37 clinical samples, a total of 69 pathogenic variants were identified, comprising 65 CYP21A2 variants, 2 HSD3B2 variants, and 2 CYP17A1 variants. For CYP21A2, the most frequent variant was c.518T > A (29.2%), followed by c.293-13C/A > G (21.5%). Compared with the current CAH testing using MLPA plus Sanger sequencing, the CACAH assay showed 100% specificity and 100% sensitivity, and precisely determined the junction sites of deletions/insertions and cis-trans configuration of multiple variants without analyzing family samples. Moreover, CACAH identified a case carrying 2 copies of CYP21A1 with the c.1451_1452delinsC variant on the same chromosome, which was not confirmed by MLPA plus Sanger sequencing.

Conclusion: LRS-based CACAH can determine all genotypes of CAH accurately and reliably in one assay, presenting a comprehensive approach for CAH genetic diagnosis and carrier screening.

Citing Articles

Targeted long-read sequencing facilitates effective carrier screening for complex monogenic diseases including spinal muscular atrophy, α-/β-thalassemia, 21-hydroxylase deficiency, and fragile-X syndrome.

Li S, Hua R, Han X, Xu Y, Li M, Gao L J Transl Med. 2025; 23(1):307.

PMID: 40069872 PMC: 11895162. DOI: 10.1186/s12967-025-06345-1.


Targeted long-read sequencing enables higher diagnostic yield of ADPKD by accurate PKD1 genetic analysis.

Sun Q, Xu P, Mao A, Huang S, Li J, Chen L NPJ Genom Med. 2025; 10(1):22.

PMID: 40069205 PMC: 11897170. DOI: 10.1038/s41525-025-00477-5.


Comparative study of third-generation sequencing-based CASMA-trio and STR linkage analysis for identifying SMN1 2 + 0 carriers.

He J, He W, Xian J, Wang Y, Ma X, Lin S Sci Rep. 2025; 15(1):6388.

PMID: 39984716 PMC: 11845760. DOI: 10.1038/s41598-025-90603-1.


High clinical utility of long-read sequencing for precise diagnosis of congenital adrenal hyperplasia in 322 probands.

Wang Y, Zhu G, Li D, Pan Y, Li R, Zhou T Hum Genomics. 2025; 19(1):3.

PMID: 39810276 PMC: 11731552. DOI: 10.1186/s40246-024-00696-4.


Haplotype-Resolved Genotyping and Association Analysis of 1,020 β-Thalassemia Patients by Targeted Long-Read Sequencing.

Ye Y, Niu C, Mao A, Qin L, Zhan J, Chen W Adv Sci (Weinh). 2024; 12(9):e2410992.

PMID: 39737841 PMC: 11884621. DOI: 10.1002/advs.202410992.